BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11455153)

  • 1. Mycophenolate mofetil for dermatomyositis.
    Tausche AK; Meurer M
    Dermatology; 2001; 202(4):341-3. PubMed ID: 11455153
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis.
    Edge JC; Outland JD; Dempsey JR; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):65-9. PubMed ID: 16415388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil in dermatomyositis: is it safe?
    Rowin J; Amato AA; Deisher N; Cursio J; Meriggioli MN
    Neurology; 2006 Apr; 66(8):1245-7. PubMed ID: 16636243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
    Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A
    Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels.
    Göttfried I; Seeber A; Anegg B; Rieger A; Stingl G; Volc-Platzer B
    Eur J Dermatol; 2000; 10(1):29-35. PubMed ID: 10694294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases.
    Gelber AC; Nousari HC; Wigley FM
    J Rheumatol; 2000 Jun; 27(6):1542-5. PubMed ID: 10852287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyopathic dermatomyositis with lung involvement responsive to mycophenolate mofetil.
    Cozzani E; Cinotti E; Felletti R; Pelucco D; Rebora A; Parodi A
    Immunopharmacol Immunotoxicol; 2013 Dec; 35(6):687-92. PubMed ID: 24004107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus.
    Williams JV; Marks JG; Billingsley EM
    Br J Dermatol; 2000 Mar; 142(3):506-8. PubMed ID: 10735959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
    Ogimi C; Honma N; Tanaka R; Oh-ishi T
    Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib.
    Apostolidis L; Kahlert C; Siegmund A; Thom R; Horstmann S; Jäger D; Lordick F
    Onkologie; 2009 Feb; 32(1-2):50-3. PubMed ID: 19209021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy.
    Williams L; Chang PY; Park E; Gorson KC; Bayer-Zwirello L
    Obstet Gynecol; 2007 Feb; 109(2 Pt2):561-3. PubMed ID: 17267895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab and mycophenolate combination therapy in refractory dermatomyositis with multiple autoimmune disorders.
    Parziale N; Kovacs SC; Thomas CB; Srinivasan J
    J Clin Neuromuscul Dis; 2011 Dec; 13(2):63-7. PubMed ID: 22361690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical spectrum of dermatomyositis].
    Kaufmann J; Hunzelmann N; Genth E; Krieg T
    J Dtsch Dermatol Ges; 2005 Mar; 3(3):181-94. PubMed ID: 16372812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
    Aslanidis S; Pyrpasopoulou A; Kartali N; Zamboulis C
    Clin Rheumatol; 2007 Jul; 26(7):1198-200. PubMed ID: 16779504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.
    Johnson HJ; Swan SK; Heim-Duthoy KL; Nicholls AJ; Tsina I; Tarnowski T
    Clin Pharmacol Ther; 1998 May; 63(5):512-8. PubMed ID: 9630824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil.
    Shipkova M; Armstrong VW; Kiehl MG; Niedmann PD; Schütz E; Oellerich M; Wieland E
    Clin Chem; 2001 Aug; 47(8):1485-8. PubMed ID: 11468247
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of dermatomyositis with the anti-signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy.
    Mizumaki K; Maeda S; Ikawa Y; Matsushita T; Takehara K; Hamaguchi Y
    J Dermatol; 2019 Jul; 46(7):e251-e253. PubMed ID: 30690762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mycophenolate mofetil for induction of remission in Wegener's granulomatosis].
    Kötter I
    Z Rheumatol; 2007 Sep; 66(5):441-3. PubMed ID: 17717676
    [No Abstract]   [Full Text] [Related]  

  • 20. [57-year old female with persistent bilateral oedema of the eyelids. Paraneoplastic dermatomyositis].
    Fierlbeck I; Hartmann M
    J Dtsch Dermatol Ges; 2009 Jul; 7(7):639-40. PubMed ID: 19614813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.